ストックスクリーナーアプリを入手
0.708
1.87%
0.013
アフターアワーズ：
.69
-0.018
-2.54%
Aethlon Medical Inc (AEMD) 最新ニュース
Aethlon Medical Announces $4 Million At-the-Market Offering to Advance Cancer and Infectious Disease Therapies - Minichart
Aethlon Medical Announces July 2026 Financing Offering - TipRanks
Aethlon Medical (NASDAQ: AEMD) prices $4M follow-on at-the-market deal - Stock Titan
Aethlon Medical Raises ~$4.0 Million in Registered Offering Priced at $0.71; Maxim Group as Agent - TradingView
Aethlon Medical (AEMD) launches $0.71 unit offering registering 11.2M shares - Stock Titan
[EFFECT] AETHLON MEDICAL INC SEC Filing - Stock Titan
AEMDAethlon Medical Inc Latest SEC Filings - Finviz
Aethlon Medical prices $4M follow-on offering at $0.7101 - scanx.trade
Aethlon Medical prices $4M follow-on offering at $0.71 per share - Investing.com
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - Yahoo Finance
AEMD Q2 2026 Earnings: EPS Beat Highlights Cost Discipline Amid Pre-Revenue PhaseEarnings Preview - dars.gov.et
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
Form 4 Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax - Stock Titan
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax withholding - Stock Titan
Director at Aethlon Medical (AEMD) forfeits 1,091 shares for tax withholding - Stock Titan
Form S-1/A AETHLON MEDICAL For: 1 July By Investing.com - Investing.com UK
Aethlon Medical (AEMD) updates S-1 with auditor consent, expenses - Stock Titan
Form S-1/A Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (NASDAQ: AEMD) targets $4M unit offering of shares and warrants - Stock Titan
AEMD Q2 2021 Earnings Call - BigGo ファイナンス
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Aethlon Medical (AEMD) Slides 2.22% as Support Level Nears – Key Levels in FocusImbalance Zone - dars.gov.et
Aethlon Medical (AEMD) Reveals Key Research on Long COVID and Ex - GuruFocus
Aethlon Medical study links device to Long COVID markers - Investing.com UK
Aethlon Medical reports two-fold Long COVID signal - grafa.com
Breakthrough Long COVID Biomarker Identified by Aethlon Medical (Nasdaq: AEMD) Opens Door for Hemopurifier Treatment - Investorideas.com
Biotech's Rapid Response to the 2026 Ebola Outbreak: Vaccines, Antibodies, and Therapeutics Advance - Investorideas.com
Aethlon Medical study links device to Long COVID markers By Investing.com - Investing.com Canada
Aethlon study links Long COVID vesicles to Hemopurifier capture - Stock Titan
Price to sales forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Price to earnings forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Aethlon Medical tracks Ebola outbreak, readies Hemopurifier talks - Stock Titan
Aethlon Medical, Inc. Actuals & Estimates (NASDAQ:AEMD) - TradingView
Enterprise value to EBIT forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
AEMD Forecast — Price Target — Prediction for 2027 - TradingView
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Form S-1 Aethlon Medical Inc For: 22 June By Investing.com - Investing.com Nigeria
Aethlon Medical (AEMD) files S-1 for $12M stock and warrant offering - Stock Titan
Aethlon Medical | S-1: General form for registration of securities under the Securities Act of 1933 - Moomoo
Aethlon Medical (AEMD) Slips 1.05% as Shares Test Key Support Near $1.80Initial Balance - dars.gov.et
AEMD News | AETHLON MEDICAL INC (NASDAQ:AEMD) - ChartMill
Aethlon Medical advances Hemopurifier study as final trial cohort nears completion - Proactive financial news
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aethlon Medical Inc (AEMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aethlon Medical Inc (AEMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aethlon Medical Inc (AEMD) Institutional Confidence - TradingKey
Aethlon Medical Inc (AEMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call Highlights: Str - GuruFocus
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionCash Flow Report - newsline.com
AEMD Q1 2026 Earnings: Slight EPS Beat Amid Pre-Revenue Status, Stock Gains Over 6%Revenue Estimate Trend - lwvtexas.org
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Lifts SharesEarnings Volatility Report - newsline.com
Earnings call transcript: Aethlon Medical Q4 2026 reveals financial strides By Investing.com - Investing.com India
Aethlon Medical (AEMD) Reports Q4 2026 Progress in Hemopurifier Trials - GuruFocus
Aethlon Medical Q4 2026 Earnings Call Transcript - MarketBeat
Aethlon outlines cohort 3 expansion to 3–6 patients as Hemopurifier oncology trial advances - MSN
Aethlon Medical FY2026 Earnings: Hemopurifier Advances and Financial OverviewNews and Statistics - IndexBox
Aethlon (AEMD) Q4 2026 Earnings Transcript - The Globe and Mail
Aethlon Medical Reports Fiscal 2026 Results, Clinical Progress - TipRanks
2.36%
大文字化:
|
ボリューム (24 時間):